Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Baricitinib is the most effective treatment for alopecia areata.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Indinavir and ritonavir therapy can cause reversible hair loss.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.